Integrum AB (publ) (INTEG-B.ST)
SEK 18.65
(3.04%)
SEK 18.65
(3.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 164.85 Million SEK | -0.19% |
| 2022 | 165.16 Million SEK | -8.46% |
| 2021 | 180.43 Million SEK | 384.93% |
| 2020 | 37.2 Million SEK | 15.57% |
| 2019 | 32.19 Million SEK | 29.28% |
| 2018 | 24.9 Million SEK | -5.6% |
| 2017 | 26.38 Million SEK | 33.42% |
| 2016 | 19.77 Million SEK | 94.44% |
| 2015 | 10.16 Million SEK | 58.49% |
| 2014 | 6.41 Million SEK | -25.77% |
| 2013 | 8.64 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 199.75 Million SEK | 21.17% |
| 2023 FY | 164.85 Million SEK | -0.19% |
| 2023 Q1 | 158.44 Million SEK | -4.07% |
| 2023 Q4 | 164.85 Million SEK | -0.79% |
| 2023 Q3 | 166.17 Million SEK | 2.63% |
| 2023 Q2 | 161.91 Million SEK | 2.19% |
| 2022 Q2 | 167.89 Million SEK | -1.58% |
| 2022 Q4 | 165.16 Million SEK | 3.94% |
| 2022 FY | 165.16 Million SEK | -8.46% |
| 2022 Q1 | 170.59 Million SEK | -5.46% |
| 2022 Q3 | 158.9 Million SEK | -5.36% |
| 2021 Q3 | 171.4 Million SEK | -2.92% |
| 2021 Q2 | 176.55 Million SEK | 16.89% |
| 2021 Q1 | 151.03 Million SEK | 305.92% |
| 2021 FY | 180.43 Million SEK | 384.93% |
| 2021 Q4 | 180.43 Million SEK | 5.27% |
| 2020 Q3 | 35.77 Million SEK | 4.12% |
| 2020 FY | 37.2 Million SEK | 15.57% |
| 2020 Q4 | 37.2 Million SEK | 4.02% |
| 2020 Q2 | 34.35 Million SEK | 19.07% |
| 2020 Q1 | 28.85 Million SEK | -10.38% |
| 2019 Q4 | 32.19 Million SEK | 8.99% |
| 2019 FY | 32.19 Million SEK | 29.28% |
| 2019 Q1 | 26.69 Million SEK | 7.18% |
| 2019 Q2 | 25.29 Million SEK | -5.22% |
| 2019 Q3 | 29.53 Million SEK | 16.76% |
| 2018 Q4 | 24.9 Million SEK | -25.59% |
| 2018 FY | 24.9 Million SEK | -5.6% |
| 2018 Q1 | 19.24 Million SEK | -27.05% |
| 2018 Q2 | 42.73 Million SEK | 122.05% |
| 2018 Q3 | 33.46 Million SEK | -21.69% |
| 2017 FY | 26.38 Million SEK | 33.42% |
| 2017 Q2 | 42.55 Million SEK | 0.91% |
| 2017 Q1 | 42.17 Million SEK | 113.31% |
| 2017 Q3 | 33.2 Million SEK | -21.99% |
| 2017 Q4 | 26.38 Million SEK | -20.54% |
| 2016 Q4 | 19.77 Million SEK | -6.61% |
| 2016 Q3 | 21.17 Million SEK | 0.0% |
| 2016 Q1 | - SEK | -100.0% |
| 2016 FY | 19.77 Million SEK | 94.44% |
| 2015 FY | 10.16 Million SEK | 58.49% |
| 2015 Q4 | 10.16 Million SEK | 0.0% |
| 2014 FY | 6.41 Million SEK | -25.77% |
| 2013 FY | 8.64 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -162.164% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 94.985% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 94.985% |
| Arcoma AB | 81.96 Million SEK | -101.141% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 75.858% |
| BICO Group AB (publ) | 10.19 Billion SEK | 98.383% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 78.167% |
| CellaVision AB (publ) | 928.71 Million SEK | 82.249% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -185.594% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -650.879% |
| C-Rad AB (publ) | 404 Million SEK | 59.193% |
| Duearity AB (publ) | 15.14 Million SEK | -988.61% |
| Dignitana AB (publ) | 44.83 Million SEK | -267.735% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -58.062% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.701% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -60.621% |
| Iconovo AB (publ) | 128.07 Million SEK | -28.716% |
| Luxbright AB (publ) | 40.68 Million SEK | -305.192% |
| Mentice AB (publ) | 322.52 Million SEK | 48.885% |
| OssDsign AB (publ) | 356.38 Million SEK | 53.742% |
| Paxman AB (publ) | 167.12 Million SEK | 1.356% |
| Promimic AB (publ) | 92.87 Million SEK | -77.506% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -322.218% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -156.255% |
| ScandiDos AB (publ) | 81.47 Million SEK | -102.348% |
| Sectra AB (publ) | 3.21 Billion SEK | 94.866% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 83.743% |
| Senzime AB (publ) | 433.54 Million SEK | 61.974% |
| SpectraCure AB (publ) | 144.83 Million SEK | -13.826% |
| Stille AB | 804.89 Million SEK | 79.518% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 98.994% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 92.491% |